|
|
|
«
1-A
B
C-D
E-G
H-L
M
N-O
P
Q-R
S
T-U
V-Z
»
«
5AM
Aper
»
|
 |
|
|
Aperion Partners
Offices: Framingham, Massachusetts
Apeiron Partners is a boutique investment
bank focused exclusively on the life sciences.
Apeiron is their new corporate brand replacing
CPP Advisors, which many of you already
know. With a new set of exciting transaction
mandates, the changing market environment
and the publication of their first book,
they too felt the need for change. |
Aphelion Capital
Offices: San Francisco, California
Aphelion Capital makes public and private
investments in the medical technology industry.
They leverage its substantial medical technology
knowledge and deep networks to enhance returns
for both the fund and the entrepreneurs
in whom the fund invests. The fund is generally
a long term investor in companies that they
believe have superior products and strong
management teams. Aphelion prefers private
investments where they can partner with
the company to enhance success and value
appreciation. |
Apjohn Group
Offices: Kalamazoo, Michigan
Apjohn Group is an accomplished team of
experienced business and pharmaceutical
professionals that has demonstrated success
in working with innovators to launch life
science companies. Their focus is on early
stage life science opportunities, with unique
strength in biopharmaceuticals. The fourteen
partners in Apjohn Group have broad and
deep expertise, as well extensive networks,
in all phases of the drug development process,
from discovery through commercialization.
|
Apposite Capital
Offices: London, England
Apposite extensive entrepreneurial, private
equity and investment banking skills, all
focussed on healthcare, allow us to add
value to companies throughout their investment
period. They have built an extensive network
of relationships across the world, including
with many prestigious advisers and institutions.
This network, combined with the unrivalled
reach into Japan that comes from their backing
by major Japanese corporates, allows them
to provide their companies with invaluable
introductions and insights on a global basis. |
|
|
Aravis General Partners
Offices: Zurich, Switzerland
Aravis is an investment organization providing
venture capital to highly promising seed
and early-stage as well as spin-off biotechnology
companies developing break-through technologies
or new therapeutics. Aravis offers its portfolio
companies a unique international network
that combines decades of experience in science,
operations and venture financing. Aravis’
worldwide network within their partners
opens doors in a number of geographic locations. |
Arboretum Ventures
Offices: Ann Arbor, Michigan
Arboretum Ventures is a venture capital
firm targeting investments in early-stage
life sciences companies. Their areas of
focus include: medical devices and diagnostics;
pharmaceuticals and biotechnology; and,
health care services. Arboretum makes seed
and early-stage investments, often representing
the founder’s first professional investor.
As such, Arboretum’s principals remain actively
involved with the portfolio companies, working
directly with company founders to help establish
business models. |
Ascension Health Ventures
Offices: St Louis, Missouri
A strategic healthcare venture fund focused
on the medical device, technology and service
sectors. Established within Ascension Health,
to invest in the future of its 400 year
legacy, AHV’s role is to construct and manage
a strategic portfolio of investments that
deliver a venture investment return, have
the potential to transform the healthcare
industry and significantly enhance the quality
of patient care. |
Astella Venture Management
Offices: Los Altos, California
Investment in emerging biotechnology companies,
Astellas Venture Management is the corporate
venture capital arm of Astellas Pharma,
a global pharmaceutical company originated
in Japan. The venture capital activity of
Astella can trace back to Astellas Venture
Capital (originally founded as Yamanouchi
VentureCapital n 2000) and Fujisawa Investments
for Entrepreneurship established in 1999.
Astella Venture Management is currently
managing four funds. |
Avlar Bio Ventures
Offices: Cambs, England
Avlar was founded in 1999 and manages Avlar
Fund I (£21m) and Avlar Fund II (£43m).
Avlar has invested in eighteen companies
across a range of sub-sectors of the bioscience
industries. Prior to the formation of Avlar
Messrs Roach and Goodman co-founded or seed
financed nine life science companies. Seven
of these were listed on recognized Stock
Exchanges producing highly profitable realizations.
These included Acambis, Chiroscience, Core,
Salix and Oxford Biomedica. |
|
|
|
|
|
|
|
Bio
Life (-Bay City-)
Resources
to
top